Literature DB >> 17920383

Statins and vitamin D.

John F Aloia, Melissa Li-Ng, Simcha Pollack.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17920383      PMCID: PMC2075568          DOI: 10.1016/j.amjcard.2007.05.024

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  10 in total

1.  A randomized controlled trial of vitamin D3 supplementation in African American women.

Authors:  John F Aloia; Sonia Arunabh Talwar; Simcha Pollack; James Yeh
Journal:  Arch Intern Med       Date:  2005-07-25

2.  Statins modulate the levels of osteoprotegerin/receptor activator of NFkappaB ligand mRNA in mouse bone-cell cultures.

Authors:  H Kaji; M Kanatani; T Sugimoto; K Chihara
Journal:  Horm Metab Res       Date:  2005-10       Impact factor: 2.936

3.  [Iatropathogenic effect of Mevacor on vitamin D metabolism].

Authors:  H Wilczek; J Sobra; V Justová; R Ceska; Z Jůzová; R Procházková; M Kvasilová; V Pacovský
Journal:  Cas Lek Cesk       Date:  1989-09-29

4.  Effects of pravastatin and cholestyramine on circulating levels of parathyroid hormone and vitamin D metabolites.

Authors:  F Ismail; C N Corder; S Epstein; G Barbi; S Thomas
Journal:  Clin Ther       Date:  1990 Sep-Oct       Impact factor: 3.393

Review 5.  Hydroxymethylglutaryl-coenzyme A reductase inhibitors and osteoporosis: a meta-analysis.

Authors:  Christos Hatzigeorgiou; Jeffrey L Jackson
Journal:  Osteoporos Int       Date:  2005-03-03       Impact factor: 4.507

6.  Effects of Atorvastatin on vitamin D levels in patients with acute ischemic heart disease.

Authors:  José L Pérez-Castrillón; Gemma Vega; Laura Abad; Alberto Sanz; José Chaves; Gonzalo Hernandez; Antonio Dueñas
Journal:  Am J Cardiol       Date:  2007-02-08       Impact factor: 2.778

7.  Effects of pravastatin treatment on vitamin D metabolites.

Authors:  M Montagnani; F Loré; G Di Cairano; S Gonnelli; C Ciuoli; A Montagnani; C Gennari
Journal:  Clin Ther       Date:  1994 Sep-Oct       Impact factor: 3.393

8.  Effects of pravastatin, a new HMG-CoA reductase inhibitor, on vitamin D synthesis in man.

Authors:  A S Dobs; M A Levine; S Margolis
Journal:  Metabolism       Date:  1991-05       Impact factor: 8.694

9.  [Monitoring plasma levels of vitamin D metabolites in simvastatin (Zocor) therapy in patients with familial hypercholesterolemia].

Authors:  H Wilczek; J Sobra; R Ceska; V Justová; Z Jůzová; R Procházková; M Kvasilová
Journal:  Cas Lek Cesk       Date:  1994-12-05

10.  Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells.

Authors:  Toyonobu Maeda; Ayako Matsunuma; Izuru Kurahashi; Toru Yanagawa; Hiroshi Yoshida; Noboru Horiuchi
Journal:  J Cell Biochem       Date:  2004-06-01       Impact factor: 4.429

  10 in total
  10 in total

1.  Baseline Vitamin D Deficiency Decreases the Effectiveness of Statins in HIV-Infected Adults on Antiretroviral Therapy.

Authors:  Corrilynn O Hileman; Vin Tangpricha; Abdus Sattar; Grace A McComsey
Journal:  J Acquir Immune Defic Syndr       Date:  2017-04-15       Impact factor: 3.731

2.  The JUPITER lipid lowering trial and vitamin D: Is there a connection?

Authors:  William R Ware
Journal:  Dermatoendocrinol       Date:  2010-04

3.  Brazilian consensus on photoprotection.

Authors:  Sérgio Schalka; Denise Steiner; Flávia Naranjo Ravelli; Tatiana Steiner; Aripuanã Cobério Terena; Carolina Reato Marçon; Eloisa Leis Ayres; Flávia Alvim Sant'anna Addor; Helio Amante Miot; Humberto Ponzio; Ida Duarte; Jane Neffá; José Antônio Jabur da Cunha; Juliana Catucci Boza; Luciana de Paula Samorano; Marcelo de Paula Corrêa; Marcus Maia; Nilton Nasser; Olga Maria Rodrigues Ribeiro Leite; Otávio Sergio Lopes; Pedro Dantas Oliveira; Renata Leal Bregunci Meyer; Tânia Cestari; Vitor Manoel Silva dos Reis; Vitória Regina Pedreira de Almeida Rego
Journal:  An Bras Dermatol       Date:  2014 Nov-Dec       Impact factor: 1.896

Review 4.  The association between drugs frequently used by the elderly and vitamin D blood levels: a review of observational and experimental studies.

Authors:  Anne Claire B van Orten-Luiten; André Janse; Rosalie A M Dhonukshe-Rutten; Renger F Witkamp
Journal:  Drugs Aging       Date:  2014-02       Impact factor: 3.923

5.  Vitamin D3 supplementation scheme in HIV-infected patients based upon pharmacokinetic modelling of 25-hydroxycholecalciferol.

Authors:  Frantz Foissac; Jean-Marc Tréluyer; Jean-Claude Souberbielle; Hafeda Rostane; Saïk Urien; Jean-Paul Viard
Journal:  Br J Clin Pharmacol       Date:  2013-05       Impact factor: 4.335

6.  25-hydroxyvitamin D insufficiency is associated with impaired renal endothelial function and both are improved with rosuvastatin treatment.

Authors:  Christian Ott; Ulrike Raff; Markus P Schneider; Stephanie I Titze; Roland E Schmieder
Journal:  Clin Res Cardiol       Date:  2012-12-21       Impact factor: 5.460

Review 7.  Drug-vitamin D interactions: a systematic review of the literature.

Authors:  Kim Robien; Sarah J Oppeneer; Julia A Kelly; Jill M Hamilton-Reeves
Journal:  Nutr Clin Pract       Date:  2013-01-10       Impact factor: 3.080

8.  Vitamin D deficiency as adverse drug reaction? A cross-sectional study in Dutch geriatric outpatients.

Authors:  A C B van Orten-Luiten; A Janse; R A M Dhonukshe-Rutten; R F Witkamp
Journal:  Eur J Clin Pharmacol       Date:  2016-02-12       Impact factor: 2.953

9.  Simvastatin does not affect vitamin d status, but low vitamin d levels are associated with dyslipidemia: results from a randomised, controlled trial.

Authors:  Lars Rejnmark; Peter Vestergaard; Lene Heickendorff; Leif Mosekilde
Journal:  Int J Endocrinol       Date:  2009-07-21       Impact factor: 3.257

10.  Simvastatin Treatment Does Not Affect Serum Vitamin D Concentrations in Patients with Dyslipidemia: A Randomized Double-blind Placebo-controlled Cross-over Trial.

Authors:  Mohsen Mazidi; Haleh Rokni; Amir Hossein Sahebkar; Akram Mohammadi; Majid Ghayour-Mobarhan; Gordon A Ferns
Journal:  Int J Prev Med       Date:  2016-06-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.